Archive: European Medicines Agency

Showing 561 to 570 of 575 entries

	Title
2005-03-01	Website: EMEA implementation of the new EU pharmaceutical legislation Author (Corporate): European Medicines Agency Published: March 2005 (Last update: 01/03/2005)
2005-03-01	Survey on the performance of EMEA scientific procedures for medicinal products for human use 2004 Author (Corporate): European Medicines Agency Published: March 2005 (Last update: 01/03/2005)
2005-02-17	European Medicines Agency announces regulatory action on COX-2 inhibitors Author (Corporate): European Medicines Agency Series Details: Public Statement EMEA/62757/2005 (17.2.05) Published: 17/02/2005 (Last update: 17/02/2005)
2005-02-16	Work programme for the European Medicines Agency 2005 Author (Corporate): European Medicines Agency Published: 16/02/2005 (Last update: 16/02/2005)
2005-01-20	Environmental risk assessments for medicinal products containing or consisting of genetically modified organisms (GMOs) (Module 1.6.2) Consultation document Author (Corporate): European Medicines Agency Published: 20/01/2005 (Last update: 20/01/2005)
2005-01-20	Press Release: Update from the European Medicines Agency on COX-2 inhibitors Author (Corporate): European Medicines Agency Series Details: Press Release EMEA/23547/2005 (20.1.05) Published: 20/01/2005 (Last update: 20/01/2005)
2005-01-12	Guideline on user safety for pharmaceutical veterinary medical products Author (Corporate): European Medicines Agency Published: 12/01/2005 (Last update: 12/01/2005)
2004-12-17	Press Release: Management board finalises its long-term plan and adopts work programme and budget for 2005 Author (Corporate): European Medicines Agency Series Details: Press Release EMEA/204096/2004 (17.12.04) Published: 17/12/2004 (Last update: 17/12/2004)
2004-10-28	Medicines for children: The European paediatric initiative Author (Corporate): European Medicines Agency Published: 28/10/2004 (Last update: 28/10/2004)
2004-10-04	Press Release: EMEA and FDA publish implementation plan for confidentiality arrangement Author (Corporate): European Medicines Agency Series Details: Press Release EMEA/93356/2004 (4.10.04) Published: 04/10/2004 (Last update: 04/10/2004)